Stomach Neoplasm

• CLINICAL_TRIALS trial_result · 2024-02-07
  Clinical Trial Update: Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction [Phase 2]

  Phase 2 clinical trial evaluating Ocoxin-Viusid in advanced stomach cancer and related gastric/esophagogastric junction cancers has been com…

• CLINICAL_TRIALS trial_result · 2022-12-09
  Clinical Trial Update: The Effect of Carboxymetyl Starch (Oozfix) on Preventing Postoperative Complication After Gastrectomy [Phase 4]

  A Phase 4 trial assessing whether Carboxymethyl Starch (Oozfix) reduces postoperative complications after gastrectomy.

• CLINICAL_TRIALS trial_result · 2022-11-30
  Clinical Trial Update: Vactosertib and Durvalumab in Gastric Cancer [Phase 2]

  Phase 2 trial update for Vactosertib with Durvalumab in stomach neoplasm (gastric cancer) is ongoing with an unknown status.

• CLINICAL_TRIALS trial_result · 2022-11-15
  Clinical Trial Update: Neoadjuvant Immunotherapy and Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial [Phase 2]

  Phase 2 trial update on neoadjuvant immunotherapy combined with chemotherapy for locally advanced esophagogastric junction and gastric cance…

• CLINICAL_TRIALS trial_result · 2020-02-05
  Clinical Trial Update: Clinical Outcomes of Laparoscopic D1 Versus D2 Lymphadenectomy for Elderly Patients With Advanced Gastric Cancer [Phase 2]

  Phase 2 clinical trial update comparing laparoscopic D1 versus D2 lymphadenectomy for elderly patients with advanced gastric cancer.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-01-07
  Clinical Trial Update: RAD001 in Advanced Gastric Cancer Who Failed Standard First-line Treatment With pS6 Ser 240/4 Expression [Phase 2]

  Phase 2 trial update of RAD001 in advanced gastric cancer after failure of first-line therapy.

• CLINICAL_TRIALS trial_result · 2014-02-13
  Clinical Trial Update: RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line Treatment [Phase 2]

  Phase 2 trial evaluating everolimus monotherapy as salvage therapy in advanced gastric cancer after failure of standard first-line treatment…